Contact

Email

knich@unimelb.edu.au

Credentials

Position
Clinical (Professor)
Department of Medicine
ORCID

0000-0002-1297-8722

Prof Kathleen Nicholls

Clinical (Professor)
Department of Medicine
308 Scholarly works
0 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension
    DOI: 10.1038/s41467-025-68256-5
  • 2026

    Journal article

    Primary hyperoxaluria type 1—current practice in the siRNA era: an ERA Genes & Kidney Working Group survey
    DOI: 10.1093/ckj/sfag162
  • 2026

    Journal article

    Long-term effectiveness and safety of agalsidase alfa in patients with Fabry disease treated for at least 19 years: The Fabry Outcome Survey
    DOI: 10.1016/j.ymgme.2025.109477
  • 2026

    Journal article

    Isaralgagene civaparvovec (ST-920) shows positive mean annualized eGFR slope in adults with Fabry disease: Topline results from the registrational phase 1/2 STAAR gene therapy study and long-term follow-up study
    DOI: 10.1016/j.ymgme.2025.109334
  • 2026

    Journal article

    Adjusted migalastat dose regimens in patients with Fabry disease and amenable GLA variants with severe renal impairment, or with end-stage renal disease and receiving hemodialysis/hemodiafiltration (HD/HDF): Pharmacokinetic (PK) and safety results from a protocol-specified interim analysis of the RENEW study
    DOI: 10.1016/j.ymgme.2025.109485
  • 2026

    Journal article

    Effectiveness and safety outcomes in pediatric patients with Fabry disease receiving treatment with long-term agalsidase alfa: Data from the Fabry Outcome Survey
    DOI: 10.1016/j.ymgme.2025.109592
  • 2026

    Journal article

    Long-term effectiveness and safety outcomes in adults with Fabry disease treated with agalsidase alfa: 20 years of data from the Fabry Outcome Survey
    DOI: 10.1111/eci.70142
Kathleen Nicholls

RECENT SCHOLARLY WORKS